trial · primary record
SRN-101
Recurrent High-Grade Gliomas
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 6 |
| Primary completion | 2032-01-31 |
| Primary endpoint | Proportion of participants reporting treatment-emergent adverse events |
| Registry ID | NCT07826949 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:50.801Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07826949
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.